Treating Smokeless Tobacco Use in Rural Veterans
1 other identifier
interventional
123
1 country
1
Brief Summary
This is a pilot study designed in an effort to develop and improve access to effective treatments for tobacco use in rural Veterans using a tailored intervention approach. Specifically, we will evaluate a combined behavioral and pharmacological smokeless tobacco cessation which concomitantly addresses comorbid issues commonly experienced by rural tobacco users including elevated depressive symptoms, risky alcohol use, and concerns about weight gain. The objectives are to:
- 1.Evaluate the feasibility of an individually-tailored telephone intervention for rural smokeless tobacco users
- 2.Examine the impact of the intervention on treatment utilization, patient satisfaction, and smokeless tobacco cessation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 8, 2016
CompletedFirst Posted
Study publicly available on registry
December 15, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2020
CompletedJuly 24, 2019
July 1, 2019
2.8 years
December 8, 2016
July 22, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Treatment satisfaction
Participants' impressions of and satisfaction with their assigned intervention will be assessed via interview.
Three month follow-up
Secondary Outcomes (7)
Tobacco use
Three-and six-month follow-up
Alcohol use
Three- and six-month follow-up
Depressive symptoms
Three- and six-month follow-up
Body weight
Three- and six-month follow-up
Enrollment rate
Six months after study initiation
- +2 more secondary outcomes
Study Arms (2)
Tailored Intervention
EXPERIMENTALThe tailored behavioral intervention includes both behavioral and pharmacological components. The behavioral component will consist of six sessions of cognitive behavioral therapy and coping skills training delivered over the telephone. In addition, participants will be screened for conditions commonly associated with tobacco use (depressive symptoms, risky alcohol use, weight concerns) and offered supplementary behavioral treatment modules to address these issues. Participants will also be offered pharmacotherapy for tobacco cessation, with decisions regarding specific medication(s) based on patients' medical history, contraindications, prior experiences, and preferences.
Facilitated tobacco quit line referral
ACTIVE COMPARATORParticipants assigned to this condition will receive information about the VA telephone tobacco quit line and educational materials and encouraged to enroll in treatment. In addition, they will be given information regarding available medications for smoking cessation and encouraged to contact their primary care provider to discuss their options.
Interventions
Participants will receive a standard six session cognitive behavioral intervention for smokeless tobacco cessation combined with supplemental treatment modules based on individual need and preferences.
Participants with elevated depressive symptoms may receive this six session telephone-based behavioral activation intervention.
Participants with concerns about gaining weight after quitting smokeless tobacco use may receive this six session telephone-based behavioral self-management intervention designed to help attenuate post-cessation weight gain.
Participants engaging in risky alcohol use may receive this six session telephone-based behavioral intervention for reducing alcohol use.
Medication selection will be based on individual participant preferences, medical history, and contraindications.
Medication selection will be based on individual participant preferences, medical history, and contraindications.
Medication selection will be based on individual participant preferences, medical history, and contraindications.
Medication selection will be based on individual participant preferences, medical history, and contraindications.
Medication selection will be based on individual participant preferences, medical history, and contraindications.
Medication selection will be based on individual participant preferences, medical history, and contraindications. Possible combinations include nicotine patch + nicotine lozenge and nicotine patch + nicotine gum.
Medication selection will be based on individual participant preferences, medical history, and contraindications. Possible combinations include nicotine patch + bupropion, nicotine gum + bupropion, and nicotine lozenge + bupropion.
Referral to the Department of Veterans Affairs tobacco telephone quit line.
Information regarding the VA tobacco quit line and associated treatment services, self-help materials for tobacco cessation, and information about tobacco cessation medications available in the VA,
Eligibility Criteria
You may qualify if:
- Use smokeless tobacco on a daily basis
- Be willing to make a quit attempt in the next 30 days
- Reside in a rural location
- Receiving care through the Iowa City VA Health Care System or an affiliated community-based outpatient clinic
- Able to provide informed consent
- Telephone access
- Stable residence
You may not qualify if:
- Planning to move in the next 12 months
- Terminal illness
- Unstable psychiatric disorder
- Incarcerated
- Institutionalized
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mark Vander Weglead
- Iowa City VA Health Care Systemcollaborator
Study Sites (1)
Iowa City VA Healthcare System
Iowa City, Iowa, 52246, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark W. Vander Weg, PhD
Iowa City VA Health Care System
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Reserach Specialist
Study Record Dates
First Submitted
December 8, 2016
First Posted
December 15, 2016
Study Start
December 1, 2016
Primary Completion
September 1, 2019
Study Completion
May 1, 2020
Last Updated
July 24, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share